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Summary
The CyHIa • CAT fusion gene was injected into Stron-
gylocentrotus purpuratus eggs, together with excess
ligated competitor sequences representing subregions of
the Cyllla regulatory domain. In this construct, the
chloramphenicol acetyltransferase (CAT) reporter gene
is placed under the control of the 2300 nucleotide
upstream regulatory domain of the lineage-specific
CyCIa cytoskeletal actin gene. CAT mRNA was detected
by in situ hybridization in serial sections of pluteus stage
embryos derived from the injected eggs. When carrier
DNA lacking competitor CyHIa fragments was coin-
jected with Cyllla CAT, CAT mRNA was observed
exclusively in aboral ectoderm cells, i.e. the territory in
which the Cyllla gene itself is normally expressed (as
also reported by us previously). The same result was
obtained when five of seven different competitor sub-
fragments bearing sites of DNA-protein interaction
were coinjected. However, coinjection of excess quan-
tities of either of two widely separated, nonhomologous
fragments of the Cyllla regulatory domain produced a
dramatic ectopic expression of CAT mRNA in the
recipient embryos. CAT mRNA was observed in gut,
mesenchyme cells and oral ectoderm in these embryos.
We conclude that these fragments contain regulatory
sites that negatively control spatial expression of the
Cyllla gene.
Key words: sea urchin embryo, lineage specific, Cyllla actin
gene, negative spatial regulation.
Introduction
The Cyllla cytoskeletal actin gene of the sea urchin
Strongylocentrotus purpuratus is expressed during early
embryogenesis only in the eleven cell lineages that
constitute the aboral ectoderm of the pluteus (Cox et al.
1986; Cameron et al. 1989a; reviewed by Davidson,
1989). Control of Cyllla transcription depends on the
interaction with endogenous factors of cu-regulatory
sequences located within a 2300 nucleotide 5' regulat-
ory domain, as shown by gene transfer experiments
carried out with a Cyllla • CAT fusion gene construct
(Flytzanis et al. 1987; Hough-Evans et al. 1987).
Detailed mapping studies have revealed about 20 sites
within this domain where nuclear proteins bind with
high specificity in vitro (Calzone et al. 1988; Th6z6 et al.
1990). These fall into 13 distinct sequence classes,
suggesting that this number of different factors is
required in vivo. As part of an effort to determine the
biological significance of the individual elements of this
complex regulatory system, we have determined the
effect on Cyllla • CAT expression in vivo of compe-
tition for individual factors or sets of factors. Individual
subfragments of the regulatory domain, each containing
one or a few factor binding sites, were ligated together
with carrier DNA, and coinjected in excess with respect
to the Cyllla • CAT fusion into unfertilized eggs. In the
accompanying paper, Franks et al. (1990) show that
individual subfragments including the specific binding
sites for the factors P7I, P5 or P4, each competitively
depress Cyllla • CAT expression, as does a subfragment
that includes sites for two different factors called P2I
and P2II, and a subfragment that includes three other
sites, for factors P8I, P8II and P8III. Interactions with
these factors (or a least one of the P2 factors and at least
one of the P8 factors) evidently are required for normal
levels of Cyllla • CAT expression. Thus these interac-
tions mediate positive regulatory functions. Of the
remaining factors, interaction with P3B is necessary for
embryonic viability (Franks et al. 1990), while no
significant competitive depression of the level of CAT
expression was observed for subfragments bearing the
P7II, P3A, PI or P6 binding sites.
In this paper, we describe the competitive effects of
the Cyllla regulatory subfragments on the spatial rather
than the quantitative expression of Cyllla • CAT. The
cell types in which CAT mRNA is expressed in embryos
bearing excess competitor fragments were determined
by in situ hybridization, carried out on serial sections
made at an advanced stage of embryonic development.
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No qualitative effect on spatial expression was observed
with any of the subfragments found by Franks et al.
(1990) to compete for positively acting factors, viz.
those listed above. However, coinjection of two wholly
nonhomologous competitor subfragments, one contain-
ing binding sites for the factors P3B and P3A, and the
other binding sites for factor P7II, resulted in a remark-
able derangement of the spatial pattern of Cyllla • CAT
expression.
Materials and methods
Eggs and embryos
Gametes were collected and eggs injected as described
previously (McMahon et al. 1985; Franks etal. 1990). The eggs
were microinjected with approximately 2 pi of DNA solution,
either before or after fertilization, in place in the Petri dish.
Embryo samples were taken after hatching (which occurs at
18 h postfertilization) for CAT assays, and at 72 h for in situ
hybridization.
Microinjection solutions
Solutions for injection contained 40% glycerol, 250-1500
molecules of a Cyllla • CAT fusion gene per pi, and competi-
tor and/or sea urchin carrier DNA, exactly as described in
detail in the accompanying paper (Franks et al. 1990).
CAT assays
CAT enzyme content per embryo was estimated on samples of
about 50 hatched blastulae, by a method derived from that of
Gorman et al. (1982), as described by McMahon et al. (1984)
and by Franks et al. (1990).
Cytological preparation
Preparation of embryo sections and microscope slides were as
described previously (Hough-Evans et al. 1987, based on the
method of Cox et al. 1984). Embryos that developed from
eggs that had been microinjected with Cyllla • CAT or with
CyUIa • CAT plus competitor subfragments were fixed at the
desired stage (in most cases 72 h pluteus) in 1 % glutaralde-
hyde (or in 2 % paraformaldehyde, 0.5 % glutaraldehyde) in
buffer containing 2.5% NaCl, 25 mM phosphate buffer
pH7.5. Embryos enclosed in agarose boxes were embedded
in Paraplast (Monojet) or Tissueprep 2 (Fisher Scientific) and
sectioned at 5/an, and serial sections were placed on polyly-
sine-coated slides.
In situ hybridization
The single-stranded antisense CAT RNA hybridization
probes used here were transcribed as described previously
(Hough-Evans et al. 1987) from a fragment of CAT coding
sequence inserted into the polylinker of the pSP65 vector.
Either 3H- or 35S-labeled nucleotides were incorporated, as
indicated. In situ hybridization with tritiated probes was
carried out as in earlier experiments by the procedures of
Angerer and Angerer (1981) and Cox et al. (1984). These
procedures were modified for ^S-labeled probes by the
addition of 5 mM dithiothreitol and 1 % /S-mercaptoethanol to
the hybridization solution, hybridization in an N2 atmos-
phere, and posthybridization washes that included 1 %
/S-mercaptoethanol. The photographic emulsion (Kodak
NTB-2) was diluted with three parts distilled water in 3H-
probe experiments, and a 1:1 dilution was used in experiments
carried out with 35S-labeled probe.
Results
Our object in these experiments was to identify regions
of the Cyllla regulatory domain that might be required
in normal embryos -to prevent expression of the Cyllla
gene (i.e. of Cyllla-CAT), in any but the aboral
ectoderm cell lineages. The consequence of effective
competition for a regulatory factor that mediates nega-
tive control of spatial Cyllla expression would be to
induce ectopic expression in other lineages. Effective
competition of course requires that the competitor
sequences be present in sufficient quantity within the
relevant nuclei to titrate out a biologically significant
fraction of the respective factor molecules. Franks et al.
(1990) showed that this condition can indeed be met for
many different positively acting factors. In the exper-
iments described here, embryos taken from the same
competitor injection series as studied quantitatively for
CAT enzyme expression by Franks et al. (1990) were
allowed to develop to the 70-72 h pluteus stage, at
which stage serially sectioned material provides an
unequivocal orientation and identification of anatom-
ical features and tissues.
An extensive series of control experiments confirmed
that for the protocols, materials and procedures utilized
in this work, Cyllla • CAT expression is normally con-
fined to cells of the aboral ectoderm. A quantitative
summary of the results of all the available Cyllla • CAT
controls is given in Table 1. Using the criterion that
label must be present in cells of two or more adjacent
sections (to avoid artifacts of occasional random stick-
ing of labeled particulates), we found that in this recent
set of experiments (Table 1, expts 4-6), 81% of all
serially sectioned embryos display cells containing sig-
nificant detectable CATmRNA. All of these displayed
CAT mRNA in aboral ectoderm, furthermore. Three
embryos, representing 2.5 % of those studied in the
Table 1. Expression of Cyllla • CAT in pluteus-stage
embryos developed from injected eggs
Experiment
no.
1
2
3
4
5
6
Total:
Isotope
3H
3H
3H
3H
35S
3H
Labeled/
Scored*
6/26
28/50
7/7
9/9
93/118
16/19
159/229
Labeled
in aboral
ectoderm
6
28
7
9
93
16
Ectopically
labeledt
0
0
0
0
1
2
3
Embryos labeled in aboral ectodenm/S Iabeled=159/I59=100%.
Embryos labeled ectopically/2 Iabeled=3/159=2%.
Notes:
* Only embryos represented by 9 or more sections were scored.
Embryos were scored as labeled only if labeled cells appeared in
two or more adjacent sections. In later experiments (experiments 1
and 2 are from Hough-Evans et al. 1987) a larger proportion of
injected embryos were labeled, probably due to improved injection
and hybridization procedures.
t Embryos were scored as being ectopically labeled if labeled
cells were seen in tissue other than aboral ectoderm, in more than
one section.
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recent experiments (Table 1), also displayed CAT
mRNA in a few cells of other types.
Examples of control embryo sections, in which sig-
nificant fractions of the visible aboral ectoderm can be
seen to contain CAT mRNA, are shown in Fig. 1. Gut,
mesenchyme and oral ectoderm are unlabeled in these
in situ hybridizations. The single injection gene transfer
methodology used in these experiments results in
mosaic DNA incorporation patterns. Hough-Evans et
al. (1988) deduced from direct observations made by
DNA in situ hybridization to the exogenous sequences,
and other prior evidence, that most probably, in about
three-fourths of recipient embryos, a single concatenate
of the injected DNA is stably incorporated in a single
blastomere nucleus after 1 st, 2nd, 3rd or 4th cleavage.
However, exogenous DNA incorporation is random
with respect to cell type and cell lineage (Sucov et al.
1988; Franks et al. 1988a,6; Livant et al. 1988). In some
cases, the labeling patterns shown in Fig. 1 of this paper
permit us to identify those blastomeres of the early
cleavage embryo that in fact incorporated the exogen-
ous DNA, given knowledge of the regional cell lineage
of the aboral ectoderm (Cameron et al. 1987; 1989a,b).
For example, perusal of other serial sections (not
shown) of the embryo illustrated in Fig. la, upper right,
indicate that the incorporation appears to have oc-
curred in one of the two first cleavage blastomeres, viz.,
that giving rise to the 3rd cleavage blastomeres VA,
VLR and the overlying Na and NLR blastomeres, while
in the Fig. la lower embryo, incorporation appears to
have been confined to the single 3rd cleavage VA
blastomere. This evidence is important in a specific way
for our present concerns, since the VA progeny that
give rise to aboral ectoderm do not segregate from
those giving rise to gut until 6th cleavage, and from
those giving rise to skeletogenic mesenchyme until 4th
cleavage (Cameron et al. 1987). Since all aboral ecto-
derm regions of the VA domain express CAT mRNA in
this embryo, the exogenous DNA must also have been
present in gut (and probably mesenchyme cells). In
these locations, however, the Cyllla-CAT gene is
manifestly silent, an excellent demonstration of differ-
ential expression. Similar analyses of the lineage affili-
ations of labeled cells in other embryos shown are given
in the legend to Fig. 1. These observations leave no
doubt that, as reported earlier, Cyllla • CAT expression
is repressed in gut and mesenchyme, in the same
embryos in which it is active in aboral ectoderm.
Furthermore, embryos in which large NL aboral ecto-
derm domains are labeled, but the adjacent ciliary band
regions of the oral ectoderm do not express CAT
mRNA (e.g. Fig. le) show that Cyllla • CAT is not
expressed in the progeny of the 5th cleavage NLlu and
NL2u blastomeres, while it is expressed in the progeny
of their sister cells, NL11 and NL21 (Cameron et al.
1989a). However, this form of evidence cannot be
applied to the lack of expression of Cyllla • CAT in the
main facial and stomodeal region of the oral ectoderm,
as illustrated clearly in the embryos shown in Fig. la-b
(lower), If, li, and lj. These regions descend from the
single 3rd cleavage blastomere No, which gives rise only
to facial and stomadeal oral ectoderm progeny. Thus,
were incorporation of any of the exogenous
Cyllla • CAT DNA to occur in the No blastomere (or its
progeny), the resulting pluteus would be scored in these
experiments as unlabeled. For all incorporations in the
No domain at or after 3rd cleavage (i.e. the majority;
Hough-Evans et al. 1988) the expectation would thus be
that 12.5 % of the successfully injected embryos would
display no CAT mRNA, and perhaps this factor largely
accounts for the observation that in Table 1 (expts 3-6)
19 % of the embryos were scored as silent with respect
to CAT mRNA expression.
In vivo competitions that do not affect spatial
expression
Spatial expression of Cyllla • CAT was assessed in those
samples of embryos that contained the maximum
amounts of competitor DNA in the quantitative compe-
tition studies of Franks et al. (1990). Table 2 shows that
in most cases, whether or not CAT expression was
depressed by the introduction of competitor fragments,
the spatial pattern of Cyllla • CAT expression was not
affected. That is, CAT mRNA was confined to aboral
ectoderm just as in the control series summarized in
Fig. 1 and Table 1. We conclude that there is no
evidence from these experiments that the DNA-
protein interactions mediated by the subfragments,
which include the sites for factors P8I, II and III; P4;
P5; P2I or P2II, affect spatial expression of Cyllla •
CAT negatively, because no significant ectopic ex-
pression occurred. In each of these cases, we know that
the in vivo competition was effective (Franks et al.
1990). Nor was spatial expression of Cyllla • CAT
affected in the P6 competition sample; however, 'com-
petition' with this subfragment also failed to depress the
level of Cyllla • CAT expression in the experiments of
Franks et al. (1990). Therefore, for this case we lack
independent evidence that the competition was effec-
tive. A null control subfragment (designated '0'; The'ze'
et al. 1990) which contains no known sites of DNA-
protein interaction, also failed to alter spatial ex-
pression when introduced in excess as competitor.
Competition with the whole regulatory domain, while
stoichiometrically depressing CAT expression (Livant et
al. 1988; Franks et al. 1990), similarly left the spatial
pattern of expression unchanged. An obvious interpret-
ation is that titration onto competitor sequences has
sequestered required positive regulatory factors, in-
Table 2. DNA fragments of the Cyllla control region
not affecting spatial regulation
Fragment
Total no.
scored
Embryos
labeled
in aboral
ectoderm*
No. of embryos
with (possible)
ectopic
expression
P2 (I+U)
P4
P5
P6
P8 (I+n+III)
* As in Table 1;
59
48
113
70
36
see note (*).
20
11
60
57
25
0
1
0
0
1
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Fig. 1. Correct lineage-specific expression of the fusion
gene Cyllla • CAT in pluteus embryos that developed from
injected eggs. In situ hybridization to 5 /.an thick embryo
sections was carried out using a single-stranded antisense
RNA copy of the CAT gene. The probe was labeled with
35S-UTP in panels a, b, and e-j, and with 3H-UTP in panels
c and d. Embryo sections are shown under phase-contrast
and dark-field illumination, (a and b) Adjacent sections of
three embryos that expressed CAT mRNA in many cells of
the aboral ectoderm. The upper and lower right embryos
are cut approximately in sagittal section; stomach, intestine
and esophagus are visible, and the oral 'face' is toward the
right. Analysis of serial sections of the upper right embryo
establishes that label is found in cells deriving from 8-cell
blastomeres Na, VA, NLR, and VLR (Cameron era/. 1987,
1989a). Both the VA and VL blastomeres also contribute
cells to the gut, here completely unlabeled. The lower right
embryo appears to be labeled only at the apex, whose cells
are clonal descendants of the VA blastomere. The
remaining embryo (upper left) is cut so that the only tissue
seen is aboral ectoderm, except for two small groups of
ciliated band cells, (c) Embryo cut lengthwise through
stomach and intestine. Oral ectoderm is to the right. The
remaining ectoderm, including the only labeled portion, is
aboral. The labeling pattern in this embryo indicates that
the Na blastomere incorporated the exogenous Cyllla • CAT
gene, (d) Section through aboral ectoderm, intestine and
part of the stomach, on the left side of the embryo. This
side of the ectoderm (derived from blastomeres NLL and
VLL) is extensively labeled. VLL also contributes to the gut,
which is not labeled. Both mouth (and oral ectoderm) and
anus are several sections away on the slide, (e) This embryo
is cut in cross-section through the esophagus and coelomic
pouches. A small amount of oral ectoderm is present,
adjacent to the esophagus, toward the upper right. The only
labeled cells are in the patch of aboral ectoderm on the
lower right, (f) Approximately longitudinal cut through the
open mouth and esophagus (oral face, left). The aboral
ectoderm is almost completely labeled on one side, in cells
derived from NLR. (g) Two embryos cut in cross section.
The sections illustrated are toward but not in the oral face,
and all the ectoderm seen is aboral. In each embryo one
side of the ectoderm is labeled rather extensively, probably
in derivatives of an NL daughter cell of the 16-cell stage,
(h) Two embryos in which only a few cells of the aboral
ectoderm are labeled. The embryo on the left is cut in
longitudinal section through the intestine. Some NLR and
NLL (lateral ectoderm) descendants are labeled. The
embryo on the right is cut sagittally and includes a
tangential section of the stomach. In this embryo also some
but not all NLR and NLL derivatives are labeled. The oral
face of each embryo is toward the upper right of the figure,
(i and j) Approximately midsagittal sections of an embryo
that had expressed CyEUa • CAT in a majority of cells of its
aboral ectoderm (as observed in other serial sections not
shown). This implies that Na, VA, NLR, VLR, NLL and
VLL cells all contain the injected gene. Oral face, left. Note
that the labeling stops at the ciliated band (thickened cells
at the upper and lower edges of the oral face). The sections
shown are 5/an apart. Particular regions of the embryo
sections shown are indicated as follows: A, apex; B, ciliated
band; C, coelomic pouch; E, esophagus; I, intestine; M,
mouth; m, mesenchyme cell; O, oral ectoderm; S, stomach.
Oral ectoderm lies between the two lines labeled 'O'; all
the ectoderm not labeled as oral is aboral ectoderm.
Table 3. Ectopic expression of Cyllla • CAT when
competing P3 or P7II DNA fragments are injected in
molar excess
Fragment
(expt)
Total no.
embryos*
Total
labeledt
Embryos
with
ectopic
label*
Ectopic
as % of
labeled
embryos
P3(l)
P3(2)
P3(3)
P3(4)
2P3
P7II (1)
P7II (2)
P7IT(3)
2P7II
Cyma • CAT
alone§
(4)
(5,6)
47
12
13
42
114
36
46
114
194
9
137
39
9
11
35
94(82%)
35
43
110
188(97%)
9
109(80%)
20
2
6
8
36
20
31
40
91
0
3
51
22
55
23
38
57
72
36
48
0
3
* Complete embryos and embryos of which 9 or more serial
sections were scored.
t Embryos labeled in two or more sections.
t Embryos with ectopic labeling in two or more sections.
§ These results also listed in Table 1, as expts 4, 5 and 6 of that
Table. Expts 5, 6 of this series were earned out at the same time
and on the same batch of eggs as P3 (4) and P7II (3); and expt 4
similarly served as the internal control for expts P3 (3) and P7II
cluding any that might have promoted ectopic ex-
pression had they been present.
Ectopic spatial expression of Cyllla • CAT caused by
competition for P3A and Pill factors
The key result shown in this paper is illustrated in Figs 2
and 3, and summarized in Table 3. This is that in vivo
competition with two subfragments of the Cyllla regu-
latory domain results in a striking ectopic spatial
expression of Cyllla • CAT. CAT mRNA in these
samples is detected in lineages that normally never
express the Cyllla gene itself, and in which the Cyllla •
CAT construct remains silent in the absence of competi-
tor (except for 2.5 % or less of possible aberrant cases).
One of these subfragments, here referred to as the P3
subfragment, contains two known sites for high speci-
ficity DNA-binding proteins, viz- the P3A and the P3B
sites (Calzone et al. 1988; The"z6 et al. 1990). The P3B
site is an octamer protein binding site, and since
competitive titration with this site results in embryonic
lethality (Franks et al. 1990), the endogenous octamer
protein is obviously a necessary factor. The site respon-
sible for the specific spatial control function that is
perturbed in the P3 competition experiment is most
probably the P3A site. Neither a subfragment contain-
ing only this site nor the P7II site causes significant
competitive decrease in Cyllla • CAT expression even
when present in what should be sufficient excess
(Franks et al. 1990), and thus by this test neither
functions positively in vivo. The in situ hybridization
results obtained with the P3 and P7II competitions
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indicate that in fact both interactions must function
negatively in normal undisturbed embryos, presumably
preventing Cyllla expression in other than the aboral
ectoderm cell lineages. When excess molar quantities of
either of these binding sites are introduced into the
embryos, the result is a failure of these normal repres-
sive interactions, as the factors become sequestered on
the competitor fragments. Table 3 shows that from
22 % to 55 % of embryos in the P3 competition series,
and 36 % to 72 % in the P7II competition series, have at
least some cells that display illegitimate expression of
CATmRNA.
The effects of competition with the P3 and P7II
subfragments are subtly different. Fig. 2 shows rep-
resentative examples of ectopic expression with the P3
subfragment. In most cases the ectopic expression is
confined to mesenchyme cells, and in some examples a
significant fraction of the mesenchyme cells present in
the section display CAT mRNA (e.g. Fig. 2d and h).
Unfortunately we cannot clearly distinguish skeleto-
genic mesenchyme from secondary mesenchyme, since
the mineral elements of the skeleton are dissolved
during preparation. From their positions, however,
both would seem to be expressing CATmRNA: thus for
example the active mesenchyme cell along the aboral
wall of the embryo shown in Fig. 2h is likely to be
skeletogenic, while those applied to the wall of the gut
as in Fig. 2c, d, f and g are more probably secondary,
but these assignments are certainly not secure. Fig. 2
also includes some very clear examples of labeling in the
facial oral ectoderm, which descends entirely from the
progeny of the 3rd cleavage No blastomere (e.g. in
Fig. 2a, b and e). We did not see any convincing cases
among the P3 competition embryos of labeling in the
wall of the gut, however. Possible labeling in either
stomach or intestine was confined to occasional single
cells that could not be verified or supported by labeling
in the adjacent sections. Expression occurred in the
aboral ectoderm in almost all the P3 competition
embryos, whether or not they displayed ectopic CAT
mRNA as well, as can be seen, for example in the
sections shown in Fig. 2d, e and h. We conclude that the
P3 subfragment contains a regulatory element the
function of which is required to repress Cyllla ex-
pression in mesenchyme cells and oral ecoderm.
The effects of competition with the P7II fragment, as
shown in Fig. 3, are even more dramatic. The central
No domain of the oral ectoderm is strongly labeled in
Fig. 3a and b (the same embryo seen in adjacent
sections), and in Fig. 3c-f; and one side of the ciliary
band, which derives from an NL blastomere (Cameron
et al. 1989a) is strongly labeled in the embryos shown in
Fig. 3h and j . Many of the mesenchyme cells to be seen,
for example, in the embryo shown in Fig. 3g, are also
labeled. Intense labeling of cells in the wall of the gut
can be seen in the embryos shown in Fig. 3c, d and i.
Again, almost all of the labeled embryos included in the
P7II experiments of Table 3 display aboral ectoderm
labeling as well, as can be seen in Fig. 3a-h. We
conclude that the P7II interaction is required to repress
Cyllla • CAT expression (and thus presumably Cyllla
expression) in all major embryonic lineages except
aboral ectoderm. Competitive interference with this
interaction produces a catastrophic spatial derange-
ment of expression, in which expression in other lineage
element(s) wherein the exogenous DNA resides is
added to the normal pattern of aboral ectoderm ex-
pression.
Discussion
Negative spatial regulatory functions appear to be
confined to the PSA and P7II sites of the Cyllla gene
Franks et al. (1990), in the accompanying study, failed
to detect any competitive decrease in expression of
CAT mRNA from the Cyllla • CAT fusion when the
P3A or P7II subfragments were coinjected in molar
excess. From the quantities of these factors estimated in
the embryo nuclei in vivo (Calzone et al. 1988), it
appeared unlikely that this negative result could be due
to insufficient excess of the competitor sequence. The
results reported here (Table 3 and Figs 2 and 3), dem-
onstrating a frequent, and often extensive ectopic
spatial expression of CAT mRNA in the P3 and P7II
competition samples, prove that the quantities of stably
incorporated competitor sequence indeed sufficed to
titrate out the respective factors, at least in some cells of
many embryos. It follows that by the competition test
these interactions cannot function positively in regulat-
ing Cyllla • CAT expression. Present evidence suggests
that the sole function of these interactions is indeed
negative, viz., repression of Cyllla expression except in
the embryonic territory composed of the eleven aboral
ectoderm cell lineages.
We have in this work and that reported by Franks et
al. (1990) examined subfragments of the Cyllla regulat-
ory domain that include all of the known sites of high-
specificity DNA-protein interaction detected in vitro
(Calzone et al. 1988; Th6z6 et al. 1990). Only one
subfragment, that including the two sites bound by the
factor P6, failed to result either in ectopic spatial
expression or decrease in CAT expression when co-
injected in molar excess with the Cyllla • CAT fusion.
We did not examine the effect of PI site competition on
spatial expression in this work, and it is not excluded
that this interaction might also exercise negative spatial
control. However, this seems unlikely since, as Franks
et al. (1990) found, PI acts as a weak positive regulator
of Cyllla • CAT expression.
Spatial regulation of lineage-specific Cyllla gene
expression
Both of the sites that according to these results would
mediate negative spatial regulation of the Cyllla gene
are located close to one or more positively acting sites.
This is particularly clear in the case of the P7II site,
which is only about 100 nucleotides to the 3' side of the
P7I site, that was demonstrated in the accompanying
paper to function positively. This is less than the
amount of DNA bound by a single nucleosome. Thus as
in other systems in which negative regulatory interac-
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Fig. 2. In situ hybridization showing ectopic CAT expression in embryos from eggs injected with P3 DNA fragments in
competition with the CyHIa- CAT fusion gene. All the panels except h show hybridization with tritium-labeled CAT probes;
in h the probe was labeled with 35S-UTP. Embryos shown were collected in three completely independent competition
injection experiments: (1) a-d; (2) e and h; (3) f and g. Embryo regions shown: A, apex; B, ciliated band; C, coelomic
pouch, E, esophagus; I, intestine; M, mouth; m, mesenchyme cell; O, oral ectoderm; S, stomach, (a) Midsagittal section of
an embryo labeled in oral ectoderm (near the open mouth) as well as aboral ectoderm (labeling seen in one cell just aboral
(left) of the upper ciliated band; in other sections more of the aboral ectoderm was labeled). Esophagus and stomach are
visible in this section, (b) Same embryo as shown in panel a, second section further along in the series. The oral ectoderm is
labeled in several contiguous sections of this pluteus. (c) Longitudinal section through intestine, oral (upper) ectoderm, and
aboral ectoderm. The only labeling is in a mesenchyme cell attached to the gut. (d) Mesenchyme cell labeling in an embryo
cut in cross section. The intestine is cut tangentially; all the ectoderm in this section is aboral ectoderm. Two labeled
mesenchyme cells are shown. In addition, this embryo is labeled in some cells of the aboral ectoderm, (e) Tangential section
through the right side of an embryo in which the ciliary band bordering the oral face is shown on the left, heavily labeled.
The remaining tissue in this section is aboral ectoderm, (f) This embryo was sectioned through the stomach and esophagus.
A single labeled mesenchyme cell is shown, (g) Longitudinal section (oral face to the left) through esophagus and the wall of
one coelomic pouch. A mesenchyme cell above the esophagus is labeled, (h) Embryo similar to that shown in d. Some of
the mesenchyme cells seen in the phase photograph are labeled, while others are not. All of the ectoderm in this cross
section is aboral. A tangential section of part of the esophagus is completely unlabeled.
tions play an important role, a likely mechanism would
be that the negative function operates by interfering
with or modifying a physically contiguous positive
interaction. The P7I interaction might thus serve as the
essential (positive) element of the repression submech-
anism mediated by the P7II factor. Similarly, the P3A
binding site is but 13 nucleotides distant from the P3B
octamer site on the 3' side, and only 90 nucleotides
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distant from the potent, positively functioning P5 bind-
ing site (Calzone et al. 1988; The'ze' et al. 1990; Franks
etal. 1990) on the 5' side.
We cannot state on the basis of this or other extant
data whether there are positive as well as negative
lineage-specific controls on spatial expression of these
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Fig. 3. In situ hybridization of sections of pluteus stage
embryos that developed from eggs injected with
Cyllla • CAT and P7II competitor. An antisense RNA
probe to CAT mRNA was labeled with 3H-UTP (panels a,
b and g) or 35S-UTP (c, d, e, f, h and i). Photographs taken
under phase-contrast (upper) and dark-field (lower)
illumination. Embryos are labeled as in Figs 1 and 2. (a and
b) Adjacent 5 jim sections of an embryo labeled in both oral
and aboral ectoderm. This labeling pattern implies that
clonal descendants of Na and No blastomeres incorporated
the Cyllla • CAT gene. The apex ectoderm and gut are
unlabeled; therefore no cells derived from V blastomeres
contain exogenous DNA. Oral ectoderm is to the right; the
three parts of the gut, esophagus, stomach and intestine,
are clearly distinguishable, (c) Oblique section through a
pluteus in which the intestine and oral ectoderm are
labeled, as well as a portion of the aboral ectoderm
adjacent to the anus. These regions are derived from the No
and VO blastomeres, indicating that the Cyllla • CAT DNA
was probably incorporated into the oral precursor cell at the
4-cell stage. Additional labeling in the right lateral
ectoderm (sections not shown) may mean that some VLR(right anal plate) descendants also contain Cyllla • CAT.
(d) Gut (intestine) and oral ectoderm labeling in an embryo
cut in oblique cross section. The oral face is up; aboral
(lateral) ectoderm is also labeled. Our interpretation of the
labeling is that some No and NLL daughter cell clones
contain the injected gene, (e) Similar section (of a different
embryo) cut through the esophagus. The oral face is up.
Oral ectoderm (No), and aboral (Na) ectoderm as well, are
labeled, (f) Sagittal section showing aboral ectoderm
labeling near the embryo apex. Since the gut is not labeled
in this embryo, only apical ectoderm-forming VA clones
contain Cyllla • CAT. The open mouth, part of the gut and
labeled oral ectoderm (No) are to the right. In later sections
the right lateral ectoderm (NLR derivatives) is also labeled.(g) Labeled mesenchyme cells, in an embryo cut in cross
section. Aboral ectoderm is also labeled, in a few cells,
evidence of a second incorporation event, (h) Pluteus
labeled in the upper part of the ciliated band (an oral
ectoderm, No, derivative) and a few cells of aboral
ectoderm, (i and j) Two adjacent longitudinal sections
through upper gut (mouth, esophagus and coelomic sac)
and arms. Labeling is confined to the right side of the
embryo, and is absent from gut and apex; the precursors
are descendants of NLR and VLR. The oral face is to the
right, and the tips of the arms carry cells of the ciliated
band. Mouth and the ciliated band of the upper left arm are
labeled. In other sections of the same embryo (not shown)
the lower left ciliated band, but not the aboral ectoderm,
was labeled.
aboral ectoderm-specific genes. Were such to exist,
competitive titration in vivo (or deletion, or in vitro
mutations) would merely have decreased or abolished
the signal observed, as in the cases recorded in Table 2,
without altering the spatial pattern of expression. How-
ever, that same result would be expected from compe-
tition for factors that have no spatial regulatory func-
tions whatsoever, but serve as enhancers or positive
temporal regulators, etc. Even if further experiments
reveal that there are indeed lineage-specific, positively
acting factors, the negative functions displayed in this
study are a dominant regulatory feature, so that loss of
these functions ruins the lineage specificity. This is also
seen in the interspecific gene transfer experiment
(Franks et al. 1988b). The heavily ectopic pattern of
Cyllla • CAT expression observed in Lytechinus varie-
gatus embryos in that study strongly resembles that
produced in the P7II competition series of Fig. 3 of this
paper, in that expression occurs in all major lineage
elements. The direct prediction follows that in L.
variegatus nuclei the P7II factor is either missing or is
evolutionarily divergent, so that it can no longer func-
tion on the P7II site of the S. purpuratus Cyllla gene. It
appears unlikely that failure of the P3A interaction
alone to occur would suffice to explain the phenotype of
Cyllla • CAT expression in L. variegatus embryos since
competitive titration of P3A in S. purpuratus does not
generate ectopic expression in the gut (Fig. 2). The fact
that competitive interference with the P7II interaction
alone derepresses Cyllla • CAT expression in all major
lineages suggests that the regulatory system logic is of
the form that repression in oral ectoderm and mesen-
chyme requires both the P3A and P7II interactions,
while repression in gut requires only the P7II interac-
tion. Alternatively, these two interactions could have
similar functions, but there could be such large concen-
trations of P3A factor in gut cells in particular that the
incorporated competitor sequences were quantitatively
insufficient to titrate them out.
In summary, the major result of this work is the
discovery of lineage-specific, negative regulatory inter-
actions in the sea urchin embryo. These interactions are
an essential feature of the mechanism by which is
achieved the initial differential spatial expression of a
structural gene, that in normal development is tran-
scribed exclusively in the aboral ectoderm lineages of
the early embryo.
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